Entries of Zoernig, I. on the publication server
 | Up a level |
Jump to: 2018
Number of items: 1.
2018
Haag, G. M., Zoernig, I., Hassel, J. C., Halama, N., Dick, J., Lang, N., Podola, L., Funk, J., Ziegelmeier, C., Juenger, S., Bucur, M., Umansky, L., Falk, C. S. 
, Freitag, A., Karapanagiotou-Schenkel, I., Beckhove, P., Enk, A. and Jaeger, D.
(2018)
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1.
European Journal of Cancer 90, pp. 122-129.
Fulltext not available.
, Freitag, A., Karapanagiotou-Schenkel, I., Beckhove, P., Enk, A. and Jaeger, D.
(2018)
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1.
European Journal of Cancer 90, pp. 122-129.
Fulltext not available.